Leandra (Ethinylestradiol, Levonorgestrel)

Leandra, a combined oral contraceptive, acts on the hormonal regulation of the menstrual cycle.

• Contraception: Prevents pregnancy by inhibiting ovulation and modifying cervical mucus.
• Menstrual cycle regulation: Provides predictable monthly bleeding and reduces irregular periods.
• Acne treatment: Improves moderate acne associated with androgen excess in women.

• Ethinylestradiol and levonorgestrel bind to estrogen and progesterone receptors, respectively, providing negative feedback to the hypothalamic‑pituitary axis. This suppresses the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), preventing follicular development and ovulation. The progestin component also thickens cervical mucus and induces endometrial changes that reduce the likelihood of implantation.

Leandra may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild stomach upset, often resolves with continued use.
• Headache: tension‑type or migraine‑like pain.
• Breast tenderness: swelling or discomfort in the breasts.
• Spotting or breakthrough bleeding: irregular light bleeding.
• Mood changes: irritability or mild depression.
• Weight gain: modest increase in body weight.

Serious or Rare Side Effects

• Venous thromboembolism: deep‑vein clot formation.
• Pulmonary embolism: clot migration to the lungs.
• Stroke: cerebrovascular accident, especially in high‑risk individuals.
• Myocardial infarction: heart attack risk in susceptible patients.
• Severe hypertension: sudden rise in blood pressure.
• Liver tumor: benign hepatic adenoma development.

Before prescribing Leandra, clinicians should evaluate patient risk factors and counsel on safe use.

• Smoking: avoid use in women over 35 who smoke due to increased clot risk.
• History of thromboembolism: contraindicated in patients with prior clotting events.
• Liver disease: use with caution in active liver disease or dysfunction.
• Hypertension: monitor blood pressure regularly; discontinue if uncontrolled.
• Drug interactions: review concomitant medications that may reduce efficacy.
• Store at ambient temperature: keep below 25°C, protect from moisture and keep in original packaging.

Leandra can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
• Other estrogen‑containing products (e.g., hormone replacement therapy): increase risk of thrombotic events.
• Anticoagulants (e.g., warfarin): may enhance clotting risk.

Moderate Interactions (Monitor Closely)

• Antifungals such as ketoconazole: may increase hormone levels.
• Antiretrovirals (e.g., efavirenz): may lower contraceptive effectiveness.
• St. John's wort: may modestly reduce hormone concentrations.
• Certain antibiotics (e.g., griseofulvin): may slightly diminish efficacy.